These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34985402)

  • 1. Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    McElroy AN; Invernizzi R; Laskowska JW; O'Neill A; Doroudian M; Moghoofei M; Mostafaei S; Li F; Przybylski AA; O'Dwyer DN; Bowie AG; Fallon PG; Maher TM; Hogaboam CM; Molyneaux PL; Hirani N; Armstrong ME; Donnelly SC
    Am J Respir Crit Care Med; 2022 Mar; 205(5):550-562. PubMed ID: 34985402
    [No Abstract]   [Full Text] [Related]  

  • 2. The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.
    O'Dwyer DN; Armstrong ME; Trujillo G; Cooke G; Keane MP; Fallon PG; Simpson AJ; Millar AB; McGrath EE; Whyte MK; Hirani N; Hogaboam CM; Donnelly SC
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1442-50. PubMed ID: 24070541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.
    Cooke G; Kamal I; Strengert M; Hams E; Mawhinney L; Tynan A; O'Reilly C; O'Dwyer DN; Kunkel SL; Knaus UG; Shields DC; Moller DR; Bowie AG; Fallon PG; Hogaboam CM; Armstrong ME; Donnelly SC
    QJM; 2018 Apr; 111(4):217-224. PubMed ID: 29237089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity.
    Nahum A; Dadi H; Bates A; Roifman CM
    Autoimmun Rev; 2012 Mar; 11(5):341-7. PubMed ID: 22024499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.
    Studzińska M; Jabłońska A; Wiśniewska-Ligier M; Nowakowska D; Gaj Z; Leśnikowski ZJ; Woźniakowska-Gęsicka T; Wilczyński J; Paradowska E
    PLoS One; 2017; 12(1):e0169420. PubMed ID: 28046022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
    Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
    Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymorphism L412F in
    Croci S; Venneri MA; Mantovani S; Fallerini C; Benetti E; Picchiotti N; Campolo F; Imperatore F; Palmieri M; Daga S; Gabbi C; Montagnani F; Beligni G; Farias TDJ; Carriero ML; Di Sarno L; Alaverdian D; Aslaksen S; Cubellis MV; Spiga O; Baldassarri M; Fava F; Norman PJ; Frullanti E; Isidori AM; Amoroso A; Mari F; Furini S; Mondelli MU; Gen-Covid Multicenter Study ; Chiariello M; Renieri A; Meloni I
    Autophagy; 2022 Jul; 18(7):1662-1672. PubMed ID: 34964709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
    Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
    Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
    Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
    Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients.
    Lee SO; Brown RA; Razonable RR
    Transpl Infect Dis; 2013 Apr; 15(2):111-9. PubMed ID: 23240626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
    Huang Y; Ma SF; Espindola MS; Vij R; Oldham JM; Huffnagle GB; Erb-Downward JR; Flaherty KR; Moore BB; White ES; Zhou T; Li J; Lussier YA; Han MK; Kaminski N; Garcia JGN; Hogaboam CM; Martinez FJ; Noth I;
    Am J Respir Crit Care Med; 2017 Jul; 196(2):208-219. PubMed ID: 28157391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.
    Ebener S; Barnowski S; Wotzkow C; Marti TM; Lopez-Rodriguez E; Crestani B; Blank F; Schmid RA; Geiser T; Funke M
    Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L42-L55. PubMed ID: 27815256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.
    Valenzi E; Yang H; Sembrat JC; Yang L; Winters S; Nettles R; Kass DJ; Qin S; Wang X; Myerburg MM; Methé B; Fitch A; Alder JK; Benos PV; McVerry BJ; Rojas M; Morris A; Kitsios GD
    Thorax; 2021 Mar; 76(3):239-247. PubMed ID: 33268457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
    O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacterial and viral coinfection in idiopathic pulmonary fibrosis patients: the prevalence and possible role in disease progression.
    Moghoofei M; Mostafaei S; Kondori N; Armstrong ME; Babaei F
    BMC Pulm Med; 2022 Feb; 22(1):60. PubMed ID: 35148733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 3 L412F polymorphisms in infants with bronchiolitis and postbronchiolitis wheezing.
    Nuolivirta K; He Q; Vuononvirta J; Koponen P; Helminen M; Korppi M
    Pediatr Infect Dis J; 2012 Sep; 31(9):920-3. PubMed ID: 22549436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis.
    Invernizzi R; Molyneaux PL
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
    Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
    J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.